Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Eflapegrastim
Sponsor: Eunseong Medical Foundation Good GANG-AN HOSPITAL
Collaborators: Hanmi Pharmaceutical Company Limited